Sientra(R) Reports Third Quarter 2014 Financial Results

New Post Public Reply Private Reply Replies (0) Message Board
News Desk 2018
Sientra(R) Reports Third Quarter 2014 Financial Results

Highlights

  • Total net sales of $10.7 million, up 33.7% compared to the third quarter 2013
  • Total net sales of $32.6 million for the first nine months of 2014, up 25.8% compared to the same period in 2013
  • Expanded sales organization to a total of 42 representatives and managers
  • Introduced product line extension to Company's Smooth Round Breast Implant portfolio in October 2014
  • Completed Initial Public Offering in November, raising $77.2 million in net proceeds to fund commercial expansion

SANTA BARBARA, Calif., Nov. 20, 2014 (GLOBE NEWSWIRE) -- Sientra, Inc. (Nasdaq: SIEN ), a medical aesthetics company, today announced its financial results for the third quarter and nine months ended September 30, 2014.

Hani Zeini, Founder, President and Chief Executive Officer of Sientra, said, "We are pleased with the results of our third quarter and year to date 2014. The 33.7% net sales growth in the third quarter demonstrates the continued adoption of our differentiated breast implant products by board-certified plastic surgeons. Sientra's growing commercial organization continues to successfully leverage our proprietary technology and strong clinical outcomes to gain market share. Additionally, in October, we broadened our offering with the introduction of a product line extension to our Smooth Round Breast Implant portfolio. These new products provide higher fill and greater projection options for plastic surgeons and patients."

Mr. Zeini continued, "In November, we completed our IPO, a significant milestone for the Company. We thank all of our talented and dedicated employees that helped make the IPO possible and bring a passion to what they do every day. Our focus is now on deploying this new capital to further expand our commercial organization and execute on our corporate development initiatives."

Financial Review

Total net sales for the third quarter ended September 30, 2014 were $10.7 million, an increase of 33.7% compared to total net sales of $8.0 million for the same period in 2013. Total net sales for the nine months ended September 30, 2014 were $32.6 million, an increase of 25.8% compared to total net sales of $25.9 million for the same period in 2013. The increase was primarily driven by sales of the Company's breast products resulting from increased commercialization activities and greater familiarity with Sientra's products and customer service offerings by board-certified plastic surgeons.

Gross profit for the third quarter of 2014 was $7.8 million, or 73.5% of net sales, compared to gross profit of $6.0 million, or 75.3% of net sales, for the same period in 2013. Gross profit for the nine months ended September 30, 2014 was $24.3 million, or 74.6% of net sales, compared to gross profit of $19.6 million, or 75.5% of net sales, for the same period in 2013. The decrease in gross margin was primarily due to a manufacturing price increase, incremental warehouse costs, product mix and certain targeted pricing programs.

Operating expenses for the third quarter of 2014 were $8.6 million, a decrease of $3.7 million or 29.8%, compared to operating expenses of $12.2 million for the same period in 2013. For the nine months ended September 30, 2014, operating expenses totaled $27.7 million, a decrease of $7.3 million or 20.9%, compared to operating expenses of $35.0 million for the same period in 2013. The reduction is primarily due to a decrease in expenses related to the Mentor litigation, in which the Company prevailed on all claims, and the Grader Street arbitration, partially offset by an increase in employee-related expenses for the sales organization, an increase in marketing costs, and expenses related to the federal excise tax and accounting costs.

Net loss for the third quarter of 2014 was $1.5 million, compared to $6.5 million for the same period in 2013. For the nine months ended September 30, 2014 net loss was $2.6 million, compared to $16.1 million for the same period in 2013.

The Company had $19.8 million in net cash and cash equivalents as of September 30, 2014. In November 2014, Sientra completed its IPO and received aggregate net proceeds of approximately $77.2 million, after deducting underwriting discounts and commissions and estimated offering expenses.

Operational Highlights

The Company continued to expand its sales organization in the third quarter improving territory coverage. As of September 30, 2014, the Company had 42 sales representatives and managers, compared to 36 sales representatives and managers at September 30, 2013.

In October 2014, the Company introduced an extension to its Smooth Round Breast Implant portfolio. This new line extension provides plastic surgeons and their patients with additional options for higher projection and greater upper pole fullness.

The Company raised net proceeds of approximately $77.2 million in its IPO of 5,750,000 shares of its common stock, including the full exercise of the underwriters' option to purchase an additional 750,000 shares. On October 29, 2014, Sientra's shares began trading on the NASDAQ Global Select Market under the symbol, "SIEN."

Conference Call

Sientra will hold a conference call on Thursday, November 20, 2014 at 1:30pm PT/4:30pm ET to discuss its third quarter 2014 financial results. The dial-in number is (844) 464-3933 for domestic callers and (765) 507-2612 for international callers. A live webcast of the conference call will be available on the investor relations section of the Company's website at www.sientra.com .

A replay of the call will be available starting on November 20, 2014 at 4:30pm PT/7:30pm ET, through approximately 11:59pm PT on November 21, 2014. To access the replay, dial (855) 859-2056 for domestic callers and (404) 537-3406 for international callers, with the replay conference ID number 34487118. The webcast will be available in the investor relations section of the Company's website for 30 days following the completion of the call.

About Sientra

Headquartered in Santa Barbara, California, Sientra is a medical aesthetics company committed to making a difference in patients' lives by enhancing their body image, growing their self-esteem and restoring their confidence. The Company was founded to provide greater choice to board-certified plastic surgeons and patients in need of medical aesthetics products. The Company has developed a broad portfolio of products with technologically differentiated characteristics, supported by independent laboratory testing and strong clinical trial outcomes. The Company sells its breast implants and breast tissue expanders exclusively to board-certified and board-admissible plastic surgeons and tailors its customer service offerings to their specific needs. The Company also offers a range of other aesthetic and specialty products.

Forward- looking statements

This press release contains "forward-looking statements" within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended, based on management's current assumptions and expectations of future events and trends, which affect or may affect the Company's business, strategy, operations or financial performance, and actual results may differ materially from those expressed or implied in such statements due to numerous risks and uncertainties. Forward-looking statements include, but are not limited to, Sientra's ability to successfully commercialize its products, market acceptance of its products, market opportunities and ability to achieve expected growth, sales and financial results and such statements are subject to risks and uncertainties. Additional factors that could cause actual results to differ materially from those contemplated in this press release can be found in the Risk Factors section of Sientra's Registration Statement on Form S-1 and related prospectus filed with the SEC in connection with its initial public offering and its Quarterly Report on Form 10-Q. All statements other than statements of historical fact are forward-looking statements. The words ''believe,'' ''may,'' ''might,'' ''could,'' ''will,'' ''aim,'' ''estimate,'' ''continue,'' ''anticipate,'' ''intend,'' ''expect,'' ''plan,'' or the negative of those terms, and similar expressions that convey uncertainty of future events or outcomes are intended to identify estimates, projections and other forward-looking statements. Estimates, projections and other forward-looking statements speak only as of the date they were made, and, except to the extent required by law, the Company undertakes no obligation to update or review any estimate, projection or forward-looking statement.

SIENTRA, INC.
Condensed Balance Sheets
(In thousands)
(Unaudited)
     
     
Assets September 30,
2014
December 31,
2013
     
Current assets:    
Cash and cash equivalents $19,816 9,722
Accounts receivable, net 4,317 6,111
Inventories, net 19,247 21,533
Prepaid expenses and other current assets 3,782 884
Total current assets 47,162 38,250
Property and equipment, net 449 254
Goodwill 14,278 14,278
Other intangible assets, net 138 207
Other assets 248 177
Total assets $62,275 53,166
Liabilities, Convertible Preferred Stock and Stockholders' Deficit    
Current liabilities:    
Current portion of long-term debt $1,487 — 
Accounts payable 2,589 4,768
Accrued and other current liabilities 4,593 4,065
Customer deposits 7,258 4,908
Total current liabilities 15,927 13,741
Long-term debt, net of current portion 23,817 15,092
Warranty reserve and other long-term liabilities 985 550
Total liabilities 40,729 29,383
Convertible preferred stock 150,456 150,456
Stockholders' deficit:    
Total stockholders' deficit (128,910) (126,673)
Total liabilities, convertible preferred stock and stockholders' deficit $62,275 53,166
 
SIENTRA, INC.
Condensed Statements of Operations
(In thousands, except per share and share amounts)
(Unaudited)
     
  Three Months Ended
September 30,
Nine Months Ended
September 30,
  2014 2013 2014 2013
         
Net sales $10,670 7,981 32,617 25,921
Cost of goods sold 2,832 1,968 8,287 6,352
Gross profit 7,838 6,013 24,330 19,569
Operating expenses:        
Sales and marketing 4,711 4,704 16,574 15,501
Research and development 1,246 1,234 3,551 3,400
General and administrative 2,634 6,304 7,542 16,072
Total operating expenses 8,591 12,242 27,667 34,973
Loss from operations (753) (6,229) (3,337) (15,404)
Other (expense) income, net:        
Interest expense (665) (232) (1,507) (612)
Other (expense) income, net (34) (14) 2,230 (34)
Total other (expense) income, net (699) (246) 723 (646)
Loss before income taxes (1,452) (6,475) (2,614) (16,050)
Income taxes — — — —
Net loss $ (1,452) (6,475) (2,614) (16,050)
Basic and diluted net loss per share attributable to common stockholders $ (6.94) (31.45) (12.53) (66.58)
Weighted average outstanding common shares used for net loss per        
share attributable to common stockholders:        
Basic and diluted 209,344 205,901 208,648 241,057

Investor Contacts: The Ruth Group Nick Laudico / Courtney Dugan (646) 536-7030 / (646) 536-7024

Scroll down for more posts ▼

Top 10 Most Recent News Articles

AI Gives CPA Firms a New Advisory Staffing Math Today

Updated Category News Views 75

Month-end just got a lot less comfortable for firms living on the clock. Netsurit and Southwestern Talent are pitching the Virtual CFO Platform as a way for CPA firms to turn machine-led analysis into advisory work without first building a costly bench of specialists. That is not a cute workflow tweak. It goes straight at the labor model that has kept plenty of accounting...

Continue Reading
Premier Energy's €850M Debt Bet on Evryo Nears Close

Updated Category News Views 117

A Bridge Loan Gives Way to a Real Commitment Eight hundred and fifty million euros is not the sort of number a company tosses around for decoration. Premier Energy has secured a five-year senior facilities agreement to fund its planned acquisition of Evryo Group, including electricity distribution subsidiary Distribu?ie Energie Oltenia S.A., and to refinance roughly...

Continue Reading
Sokin’s UAE License Turns Expansion Into Real Payments Plumbing

Updated Category News Views 118

Dubai expansion headlines are cheap; regulated local money movement is not. That is why Sokin’s newly approved Dubai Financial Services Authority license deserves more than the usual fintech applause line. The company has paired that approval with AED accounts, local payment rails, a One Za’abeel office and a plan to double its UAE staff over the next year. None of...

Continue Reading
Vuzix Bets on Lightweight Color Glasses for OEM Partners

Updated Category News Views 174

Forty grams is where this story gets interesting, because faces are ruthless product testers. People will tolerate plenty of clever technology right up until it pinches, looks goofy, leaks light, or makes them feel like they are wearing a science project. Vuzix is trying to clear that hurdle with Ultralite Color, a full-color AI eyewear reference platform built for OEM...

Continue Reading
Telit Cinterion Tests Its Defense Connectivity Pitch

Updated Category News Views 107

Defense connectivity is a messy business, and Telit Cinterion is leaning straight into the mess at NATO Edge 2026 in Izmir, Turkey. From November 17 through 19, the company is using Booth L86 to show how several wireless links can live inside one mission-focused setup. That may sound like standard trade-show wallpaper, but the underlying problem is very real: military and...

Continue Reading
Vector's Peptide Pact Needs Proof Before Any Payday

Updated Category News Views 194

A famous orthopedic name can open doors, but it cannot manufacture clinical evidence. That is the plain reality behind Vector Science and Therapeutics' new collaboration with the Andrews Research & Education Foundation. Dr. James Andrews carries enormous credibility in sports medicine, earned across more than five decades of work. For Vector, that association matters. For...

Continue Reading
Ivanti's AI Push Rests on Data, Control and Results

Updated Category News Views 216

Enterprise AI has a nasty habit of sounding brilliant right up until it meets a messy fleet of laptops, phones, patches and permissions. Ivanti’s latest product push is aimed squarely at that unglamorous collision point: giving AI systems governed access to the operational data inside Ivanti Neurons, then keeping humans and pre-set permissions in charge of what happens...

Continue Reading
Pacific Surfliner Faces Thanksgiving Capacity Test

Updated Category News Views 122

Thanksgiving traffic on Southern California freeways is its own yearly punishment, and the Pacific Surfliner is making a sensible pitch: leave the car parked and let the coast roll past the window. For travelers, that can be a real relief. For anyone watching public transportation, this is also a useful little stress test of whether a busy state-supported rail corridor...

Continue Reading
COPD Support Program Targets a Costly Care Gap Today

Updated Category News Views 158

Breathing trouble gets shrugged off far too easily, and that casual mistake has consequences. World COPD Day puts chronic obstructive pulmonary disease back in view, with the American Lung Association emphasizing a free Lung Health Navigator program for people living with COPD, their caregivers and families. This is not flashy medicine or a miracle-cure pitch. It is...

Continue Reading
Seeking Alpha Premium Review: Data Meets Human Judgment

Updated Category News Views 148

A spreadsheet can spot a cracked windshield, but it cannot tell you where the truck is headed. That is the useful, slightly irritating truth behind Seeking Alpha Premium’s 2026 pitch: it puts an enormous amount of stock-research machinery in one place, yet the investor still has to do the driving. Software Experts has highlighted the service in its review of...

Continue Reading

Top 5 Most Recently Viewed Articles

Survey Reveals Enterprises Unready for Rising AI Power Needs

Updated Category News Views 257

Understanding the Readiness Gap in AI Power Demand Recent research sheds light on a concerning trend among enterprises regarding their preparedness to meet the escalating power demands posed by artificial intelligence (AI). Conducted by SambaNova, this survey demonstrates that while many leaders acknowledge the urgent need for energy management in AI, only a fraction...

Continue Reading
Ellevio Reports Solid Gains in H1 Despite Cash Flow Dip

Updated Category News Views 47

In a world where the electricity flows must keep pace with surging demands and regulatory labyrinths, Ellevio AB is not just hanging in there; it's pushing forward with gusto. They've just released their Half-year Report for 2026, and the numbers show a steady pulse amidst the evolving Swedish energy market conditions. With key stakeholders like OMERS Infrastructure and...

Continue Reading
Dan Orlando Releases Captivating New Music Video for Fans

Updated Category News Views 219

Dan Orlando's Artistic Journey Shines in New Video Musician Dan Orlando has just released his newest music video, 'Music In My Head.' This marks an important step in his artistic journey, showcasing his growth and dedication to producing music that resonates across various styles. A Heartfelt Connection with His Audience The video for 'Music In My Head' highlights...

Continue Reading
Revolutionizing API Testing with Parasoft's Agentic AI

Updated Category News Views 513

Parasoft Enhances API Testing with Agentic AI Parasoft, a global leader in AI-driven software testing solutions, has unveiled its latest innovation: the Agentic AI approach. This groundbreaking feature aims to transform API testing, making it more efficient and effective for software development teams. By integrating intelligent, outcome-based scenario testing, Parasoft...

Continue Reading
PPL Corporation's Growth Continues: Q1 Insights Unpacked

Updated Category News Views 193

PPL Corporation Reports Impressive First Quarter Earnings PPL Corporation (NYSE: PPL) has posted remarkable financial results for the first quarter, demonstrating solid performance and strategic execution. The company's reported earnings per share (EPS) for the quarter stands at $0.56, a significant increase compared to $0.42 in the previous year. Notably, ongoing...

Continue Reading